• español
    • English
    • français
    • português
A+A-
  • English 
    • español
    • English
    • français
    • português
    • Usage guides
      • Guidelines for the advisor work direcor
      • Guidelines for the student who loads degree work
      • APA 7 Edition Standards
      • Tips APA 7 Edition Standards
    • Users
    View Item 
    •   National Open and Distance University UNAD
    • Producción Científica
    • Sello Editorial UNAD
    • Revista Nova
    • View Item
    •   National Open and Distance University UNAD
    • Producción Científica
    • Sello Editorial UNAD
    • Revista Nova
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Recidiva de lepra y reacción tipo II en paciente tratado con poliquimioterapia (PQT)

    Relapse in leprosy and type II reaction in a patient treated with multidrug therapy (MDT)

    Relapse in leprosy and type II reaction in a patient treated with multidrug therapy (MDT)

    Thumbnail
    QRCode
    Share
    Author
    Montaño Padilla, Gina Sofía
    Lancheros González, Paula Catalina
    Celis, Luis Gustavo
    Publisher
    Universidad Colegio Mayor de Cundinamarca

    Citación

           
    TY - GEN T1 - Relapse in leprosy and type II reaction in a patient treated with multidrug therapy (MDT) T1 - Recidiva de lepra y reacción tipo II en paciente tratado con poliquimioterapia (PQT) AU - Montaño Padilla, Gina Sofía AU - Lancheros González, Paula Catalina AU - Celis, Luis Gustavo UR - https://repository.unad.edu.co/handle/10596/29918 PB - Universidad Colegio Mayor de Cundinamarca AB - ER - @misc{10596_29918, author = {Montaño Padilla Gina Sofía and Lancheros González Paula Catalina and Celis Luis Gustavo}, title = {Relapse in leprosy and type II reaction in a patient treated with multidrug therapy (MDT)Recidiva de lepra y reacción tipo II en paciente tratado con poliquimioterapia (PQT)}, year = {}, abstract = {}, url = {https://repository.unad.edu.co/handle/10596/29918} }RT Generic T1 Relapse in leprosy and type II reaction in a patient treated with multidrug therapy (MDT) T1 Recidiva de lepra y reacción tipo II en paciente tratado con poliquimioterapia (PQT) A1 Montaño Padilla, Gina Sofía A1 Lancheros González, Paula Catalina A1 Celis, Luis Gustavo LK https://repository.unad.edu.co/handle/10596/29918 PB Universidad Colegio Mayor de Cundinamarca AB OL Spanish (121)
    Bibliographic managers
    Refworks
    Zotero / EndNote / Mendeley
    BibTeX
    CiteULike
    Metadata
    Show full item record
    Abstract
    La lepra es una enfermedad infecciosa crónica propia de países de África, Asia, Oceanía y América Latina. Es causada por el Mycobacterium leprae que se manifiesta de forma variada como zonas de hipo o anestesia, máculas hipocrómicas, con o sin engrosamiento neural. En algunas ocasiones, después de haber completado el ciclo terapéutico recomendado por la Organización Mundial de la Salud, puede presentar recidivas, apareciendo nuevas lesiones clínicas o aumentando el índice bacilar. Esta características pueden confundirse con el eritema nodoso leproso, caracterizado por ser una reacción antígeno-anticuerpo que fija complemento mediante la cual el sistema inmune combate antígenos bacilares. En este texto se describe un caso de recidiva de lepra lepromatosa y lesiones compatibles con eritema nodoso leproso después de haber sido tratado con poliquimioterapia.
     
    Leprosy is a chronic infectious disease endemic to African, Asian, Latin America and South Pacific countries. It is caused by Mycobacterium leprae that manifests itself as varied as areas of hypo or anesthesia, macules hypochromic, with or without neura thickening. On some occasions, after having completed the course of therapy recommended by the World Health Organization, it can recur, showing new clinical lesions or increasing the bacillary index. These features can be confused with erythema nodosum leprosum, characterized by an antigen-antibody reaction that secures a complement through which the immune system combats antigen cells. This text describes a case of recurrence of lepromatous leprosy and lesions compatible with erythema nodosum leprosum after it has been treated with combination chemotherapy.
     
     
    College
    http://hemeroteca.unad.edu.co/index.php/nova/article/view/1000/986
    /*ref*/Rodríguez G, Pinto R. La Lepra. Imágenes y Conceptos. Medellín. Universidad de la Sabana, Universidad de Antioquia; 2007.
    /*ref*/Diana N.J. Lockwood & María Da Graca Cunha. Developing new MDT regimens for MB patients; Time to test ROM 12 month regimens globally. Lepr Rev. 2012; 83: 241–244.
    /*ref*/Gerzaín Rodríguez Toro, Rafael Pinto García. Mujer Joven con epistaxis, fiebre y nódulos cutáneos, agravados durante su segundo embarazo. Cuadernos de Medicina.2007;1(1).
    /*ref*/Gerzaín Rodríguez, María Claudia Abaúnza, Elga Vargas, Fernando López. La lepra y el Testículo. Biomédica.2012; 32:13-22.
    /*ref*/David M. Scollard. Chemotherapy of leprosy has changed (almost) everything. Lepr Rev. 2012;83:245–246.
    /*ref*/Pocaterra L, Jain S, Reddy R, Muzaffrullah S, Torres O, Suneetha S, et al. Clinical course of erythema nodosum leprosum: An 11 year cohort study in Hyderabad, India. Am J Trop Med Hyg. 2006; 74:868-79.
    /*ref*/Ministerio de Protección social. Plan estratégico de Colombia para aliviar la carga de la enfermedad y sostener las actividades de control de la lepra. 2010-2015. Bogotá: Gráficas Ducal; 2009.
    /*ref*/Organización Panamericana de la Salud (OPS). Fedesalud. Ministerio de Protección social. Guía de Atención Integral de la Lepra. 2010.
    /*ref*/Kaimal, S., & Thappa, D. M. Relapse in leprosy. Indian Journal of Dermatology, Venereology, and Leprology.2009; 75(2): 126.
    /*ref*/Shen J, Liu M, Zhang J, Su W, Ding G. Relapse in MB leprosy patients treated with 24 months of MDT in south west China: A short report. Lepr Rev. 2006; 77:219-24.
    /*ref*/Sowmya, K., & Devinder, M. Relapse in leprosy. Indian J Lepr.2009; 75:126-135.
    /*ref*/Steven L. Walker, Michael F.R. Waters & Diana N.J. Lockwood. The Role of Thalidomide in the management of erythema nodosum leprosum. Lepr Rev. 2007;78:197–215.
    /*ref*/Zhang, F. R., Huang, W., Chen, S. M., Sun, L. D., Liu, H., Li, Y.,... & Yu, J. P. Genome wide association study of leprosy. New England Journal of Medicine. 2009; 361(27): 2609-2618.
    /*ref*/Vasudha A. Belgaumkar, Neetar R. Gokhale, Pradeep M. Mahajan, Renu Bharadwaj, Dakshayani P Pandit & Shantanu Deshpande. Lepr Rev. 2007;78: 223–230.
    /*ref*/Harminder Singh, Bithika Nel, Vibek Dey, Pawan Tiwari & Naveen Dulhani. Lepr Rev. 2011; 82:17–24.
    /*ref*/Mitranna Poojabylaiah, Ramesh Bhat Marne, Rajina Varikkodan, Nandakishore Bala, Sukumar Dandakeri & Jacintha Martis. Relapses in multibacillary leprosy patients after Multidrug therapy. Lepr Rev. 2008; 79: 320-324.
    /*ref*/Laura c Rodrigues, Diana J.N Lockwood. Leprosy now: Epidemiology, progress, challenges, and research gaps. The Lancet Infectious Diseases.2011; 6:464-470.
    /*ref*/Walker, Stephen L.; Peter Nicholls; Sushmita Dhakal; Rachel Hawksworth; Murdo MacDonald,; Kishori Mahat; et al. A Comparison of the Change in Clinical Severity Scale Score and a Retrospective Physician Assessment of Neurological Outcome in Individuals with Leprosy Associated Nerve Function Impairment after Treatment with Corticosteroids. Leprosy Review. British Leprosy Relief Association. 2012.
    /*ref*/Alter, A., Alcaïs, A., Abel, L., & Schurr, E. Leprosy as a genetic model for susceptibility to common infectious diseases. Human genetics. 2008;123(3): 227-235.
    /*ref*/O.A. Chichava, L. Ariza, A.R. Oliveira, A.C. Ferreira, L.F. Marques Da Silva, J.C. Barbosa, A.N. Ramos JR & J. Heukelbach. Reasons for interrupting multidrug therapy against leprosy: The patients´ point of view. Lepr Rev. 2011; 82:78–79.
    /*ref*/Maria Pena, Annemieke Geluk, Jolien J. Van Der Ploeg- Van Schip, Kees L.M.C. Franken, Rahul Sharma & Richard Trauman. Cytokine responses to Mycobacterium leprae unique proteins differentiate between Mycobacterium leprae infected and naïve armadillos. Lepr Rev. 2011; 82: 422 – 431.
    Format
    application/pdf
    Type of digital resource
    info:eu-repo/semantics/article
    info:eu-repo/semantics/publishedVersion
    studyCase
    studyCase
    studyCase
    URI
    https://repository.unad.edu.co/handle/10596/29918
    URL source
    http://hemeroteca.unad.edu.co/index.php/nova/article/view/1000
    http://dx.doi.org/10.22490/24629448.1000
    Collections
    • Revista Nova [1177]
    Usage guidesNormativityGuidelines for the advisor work direcorGuidelines for the student who loads degree workAPA 7 Edition StandardsTips APA 7 Edition Standards

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister
    GTM statisticsGTM statistics
    Indexed by:
    logo_Open Archives Initiative
    logo_Biblioteca Digital Ecuatoriana
    logo_OpenDOAR
    logo_Open ROAR
    logo_Google Scholar
    logo_Lyrasis
    logo_WorldCat
    logo_FAO
    logo_AGRIS
    logo_Alianza de Servicios de Información Agropecuaria
    logo_Siembra
    logo_Fedesarrollo
    logo_Colombia Digital
    logo_Hemeroteca UNAD
    logo_RED DE REPOSITORIOS LATINOAMERICANOS
    logo_OAIster
    logo_La Referencia
    logo_Open AIRE
    logo_Core
    logo_Base
    logo_CLACSO
    logo_OpenAlex
    logos isopreadGreat Work to PlaceIcontec - Great Work to Place

    Línea anticorrupción: 3232641617 ext. 1544

    En Bogotá D.C. (Colombia) Teléfono: 323 264 1617 - Línea gratuita nacional: 323 264 1617

    Institución de Educación Superior sujeta a inspección y vigilancia por el Ministerio de Educación Nacional

    Universidad Nacional Abierta y a Distancia UNAD de Colombia - © Copyright UNAD 2024

    Síguenos en: